China CRISPR Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China CRISPR market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China CRISPR market. Detailed analysis of key players, along with key growth strategies adopted by CRISPR industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Editas Medicine, Inc

    • Genscript

    • Danaher Corporation

    • F Hoffmann-La Roche Ltd

    • Addgene

    • Lonza

    • Egenesis

    • AstraZeneca

    • Cellectis

    • Horizon Discovery Group Plc

    • Caribou Biosciences, Inc

    • Intellia Therapeutics, Inc

    By Type:

    • Enzymes

    • Kits and Reagents

    • Guide RNA

    • Others

    By End-User:

    • Biomedical

    • Agricultural

    • Industrial

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of CRISPR Market

    • 1.3 Market Segment by Type

    • 1.3.1 China CRISPR Market Size and Growth Rate of Enzymes from 2016 to 2027

    • 1.3.2 China CRISPR Market Size and Growth Rate of Kits and Reagents from 2016 to 2027

    • 1.3.3 China CRISPR Market Size and Growth Rate of Guide RNA from 2016 to 2027

    • 1.3.4 China CRISPR Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China CRISPR Market Size and Growth Rate of Biomedical from 2016 to 2027

    • 1.4.2 China CRISPR Market Size and Growth Rate of Agricultural from 2016 to 2027

    • 1.4.3 China CRISPR Market Size and Growth Rate of Industrial from 2016 to 2027

    • 1.4.4 China CRISPR Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of CRISPR Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of CRISPR by Major Types

    • 3.4.1 Market Size and Growth Rate of Enzymes

    • 3.4.2 Market Size and Growth Rate of Kits and Reagents

    • 3.4.3 Market Size and Growth Rate of Guide RNA

    • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of CRISPR Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of CRISPR by Major End-Users

    • 4.4.1 Market Size and Growth Rate of CRISPR in Biomedical

    • 4.4.2 Market Size and Growth Rate of CRISPR in Agricultural

    • 4.4.3 Market Size and Growth Rate of CRISPR in Industrial

    • 4.4.4 Market Size and Growth Rate of CRISPR in Others

    5 Market Analysis by Regions

    • 5.1 China CRISPR Production Analysis by Regions

    • 5.2 China CRISPR Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China CRISPR Landscape Analysis

    • 6.1 North China CRISPR Landscape Analysis by Major Types

    • 6.2 North China CRISPR Landscape Analysis by Major End-Users

    7 Central China CRISPR Landscape Analysis

    • 7.1 Central China CRISPR Landscape Analysis by Major Types

    • 7.2 Central China CRISPR Landscape Analysis by Major End-Users

    8 South China CRISPR Landscape Analysis

    • 8.1 South China CRISPR Landscape Analysis by Major Types

    • 8.2 South China CRISPR Landscape Analysis by Major End-Users

    9 East China CRISPR Landscape Analysis

    • 9.1 East China CRISPR Landscape Analysis by Major Types

    • 9.2 East China CRISPR Landscape Analysis by Major End-Users

    10 Northeast China CRISPR Landscape Analysis

    • 10.1 Northeast China CRISPR Landscape Analysis by Major Types

    • 10.2 Northeast China CRISPR Landscape Analysis by Major End-Users

    11 Southwest China CRISPR Landscape Analysis

    • 11.1 Southwest China CRISPR Landscape Analysis by Major Types

    • 11.2 Southwest China CRISPR Landscape Analysis by Major End-Users

    12 Northwest China CRISPR Landscape Analysis

    • 12.1 Northwest China CRISPR Landscape Analysis by Major Types

    • 12.2 Northwest China CRISPR Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Editas Medicine, Inc

      • 13.1.1 Editas Medicine, Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Genscript

      • 13.2.1 Genscript Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Danaher Corporation

      • 13.3.1 Danaher Corporation Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 F Hoffmann-La Roche Ltd

      • 13.4.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Addgene

      • 13.5.1 Addgene Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Lonza

      • 13.6.1 Lonza Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Egenesis

      • 13.7.1 Egenesis Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 AstraZeneca

      • 13.8.1 AstraZeneca Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Cellectis

      • 13.9.1 Cellectis Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Horizon Discovery Group Plc

      • 13.10.1 Horizon Discovery Group Plc Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Caribou Biosciences, Inc

      • 13.11.1 Caribou Biosciences, Inc Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Intellia Therapeutics, Inc

      • 13.12.1 Intellia Therapeutics, Inc Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China CRISPR Market Size and Growth Rate of Enzymes from 2016 to 2027

    • Figure China CRISPR Market Size and Growth Rate of Kits and Reagents from 2016 to 2027

    • Figure China CRISPR Market Size and Growth Rate of Guide RNA from 2016 to 2027

    • Figure China CRISPR Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China CRISPR Market Size and Growth Rate of Biomedical from 2016 to 2027

    • Figure China CRISPR Market Size and Growth Rate of Agricultural from 2016 to 2027

    • Figure China CRISPR Market Size and Growth Rate of Industrial from 2016 to 2027

    • Figure China CRISPR Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China CRISPR Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of CRISPR Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of CRISPR

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of CRISPR by Different Types from 2016 to 2027

    • Table Consumption Share of CRISPR by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Enzymes

    • Figure Market Size and Growth Rate of Kits and Reagents

    • Figure Market Size and Growth Rate of Guide RNA

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of CRISPR by Different End-Users from 2016 to 2027

    • Table Consumption Share of CRISPR by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Biomedical

    • Figure Market Size and Growth Rate of Agricultural

    • Figure Market Size and Growth Rate of Industrial

    • Figure Market Size and Growth Rate of Others

    • Table China CRISPR Production by Regions

    • Table China CRISPR Production Share by Regions

    • Figure China CRISPR Production Share by Regions in 2016

    • Figure China CRISPR Production Share by Regions in 2021

    • Figure China CRISPR Production Share by Regions in 2027

    • Table China CRISPR Consumption by Regions

    • Table China CRISPR Consumption Share by Regions

    • Figure China CRISPR Consumption Share by Regions in 2016

    • Figure China CRISPR Consumption Share by Regions in 2021

    • Figure China CRISPR Consumption Share by Regions in 2027

    • Table North China CRISPR Consumption by Types from 2016 to 2027

    • Table North China CRISPR Consumption Share by Types from 2016 to 2027

    • Figure North China CRISPR Consumption Share by Types in 2016

    • Figure North China CRISPR Consumption Share by Types in 2021

    • Figure North China CRISPR Consumption Share by Types in 2027

    • Table North China CRISPR Consumption by End-Users from 2016 to 2027

    • Table North China CRISPR Consumption Share by End-Users from 2016 to 2027

    • Figure North China CRISPR Consumption Share by End-Users in 2016

    • Figure North China CRISPR Consumption Share by End-Users in 2021

    • Figure North China CRISPR Consumption Share by End-Users in 2027

    • Table Central China CRISPR Consumption by Types from 2016 to 2027

    • Table Central China CRISPR Consumption Share by Types from 2016 to 2027

    • Figure Central China CRISPR Consumption Share by Types in 2016

    • Figure Central China CRISPR Consumption Share by Types in 2021

    • Figure Central China CRISPR Consumption Share by Types in 2027

    • Table Central China CRISPR Consumption by End-Users from 2016 to 2027

    • Table Central China CRISPR Consumption Share by End-Users from 2016 to 2027

    • Figure Central China CRISPR Consumption Share by End-Users in 2016

    • Figure Central China CRISPR Consumption Share by End-Users in 2021

    • Figure Central China CRISPR Consumption Share by End-Users in 2027

    • Table South China CRISPR Consumption by Types from 2016 to 2027

    • Table South China CRISPR Consumption Share by Types from 2016 to 2027

    • Figure South China CRISPR Consumption Share by Types in 2016

    • Figure South China CRISPR Consumption Share by Types in 2021

    • Figure South China CRISPR Consumption Share by Types in 2027

    • Table South China CRISPR Consumption by End-Users from 2016 to 2027

    • Table South China CRISPR Consumption Share by End-Users from 2016 to 2027

    • Figure South China CRISPR Consumption Share by End-Users in 2016

    • Figure South China CRISPR Consumption Share by End-Users in 2021

    • Figure South China CRISPR Consumption Share by End-Users in 2027

    • Table East China CRISPR Consumption by Types from 2016 to 2027

    • Table East China CRISPR Consumption Share by Types from 2016 to 2027

    • Figure East China CRISPR Consumption Share by Types in 2016

    • Figure East China CRISPR Consumption Share by Types in 2021

    • Figure East China CRISPR Consumption Share by Types in 2027

    • Table East China CRISPR Consumption by End-Users from 2016 to 2027

    • Table East China CRISPR Consumption Share by End-Users from 2016 to 2027

    • Figure East China CRISPR Consumption Share by End-Users in 2016

    • Figure East China CRISPR Consumption Share by End-Users in 2021

    • Figure East China CRISPR Consumption Share by End-Users in 2027

    • Table Northeast China CRISPR Consumption by Types from 2016 to 2027

    • Table Northeast China CRISPR Consumption Share by Types from 2016 to 2027

    • Figure Northeast China CRISPR Consumption Share by Types in 2016

    • Figure Northeast China CRISPR Consumption Share by Types in 2021

    • Figure Northeast China CRISPR Consumption Share by Types in 2027

    • Table Northeast China CRISPR Consumption by End-Users from 2016 to 2027

    • Table Northeast China CRISPR Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China CRISPR Consumption Share by End-Users in 2016

    • Figure Northeast China CRISPR Consumption Share by End-Users in 2021

    • Figure Northeast China CRISPR Consumption Share by End-Users in 2027

    • Table Southwest China CRISPR Consumption by Types from 2016 to 2027

    • Table Southwest China CRISPR Consumption Share by Types from 2016 to 2027

    • Figure Southwest China CRISPR Consumption Share by Types in 2016

    • Figure Southwest China CRISPR Consumption Share by Types in 2021

    • Figure Southwest China CRISPR Consumption Share by Types in 2027

    • Table Southwest China CRISPR Consumption by End-Users from 2016 to 2027

    • Table Southwest China CRISPR Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China CRISPR Consumption Share by End-Users in 2016

    • Figure Southwest China CRISPR Consumption Share by End-Users in 2021

    • Figure Southwest China CRISPR Consumption Share by End-Users in 2027

    • Table Northwest China CRISPR Consumption by Types from 2016 to 2027

    • Table Northwest China CRISPR Consumption Share by Types from 2016 to 2027

    • Figure Northwest China CRISPR Consumption Share by Types in 2016

    • Figure Northwest China CRISPR Consumption Share by Types in 2021

    • Figure Northwest China CRISPR Consumption Share by Types in 2027

    • Table Northwest China CRISPR Consumption by End-Users from 2016 to 2027

    • Table Northwest China CRISPR Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China CRISPR Consumption Share by End-Users in 2016

    • Figure Northwest China CRISPR Consumption Share by End-Users in 2021

    • Figure Northwest China CRISPR Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Editas Medicine, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Editas Medicine, Inc

    • Figure Sales and Growth Rate Analysis of Editas Medicine, Inc

    • Figure Revenue and Market Share Analysis of Editas Medicine, Inc

    • Table Product and Service Introduction of Editas Medicine, Inc

    • Table Company Profile and Development Status of Genscript

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genscript

    • Figure Sales and Growth Rate Analysis of Genscript

    • Figure Revenue and Market Share Analysis of Genscript

    • Table Product and Service Introduction of Genscript

    • Table Company Profile and Development Status of Danaher Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Danaher Corporation

    • Figure Sales and Growth Rate Analysis of Danaher Corporation

    • Figure Revenue and Market Share Analysis of Danaher Corporation

    • Table Product and Service Introduction of Danaher Corporation

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Addgene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addgene

    • Figure Sales and Growth Rate Analysis of Addgene

    • Figure Revenue and Market Share Analysis of Addgene

    • Table Product and Service Introduction of Addgene

    • Table Company Profile and Development Status of Lonza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza

    • Figure Sales and Growth Rate Analysis of Lonza

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Product and Service Introduction of Lonza

    • Table Company Profile and Development Status of Egenesis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Egenesis

    • Figure Sales and Growth Rate Analysis of Egenesis

    • Figure Revenue and Market Share Analysis of Egenesis

    • Table Product and Service Introduction of Egenesis

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Cellectis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis

    • Figure Sales and Growth Rate Analysis of Cellectis

    • Figure Revenue and Market Share Analysis of Cellectis

    • Table Product and Service Introduction of Cellectis

    • Table Company Profile and Development Status of Horizon Discovery Group Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Horizon Discovery Group Plc

    • Figure Sales and Growth Rate Analysis of Horizon Discovery Group Plc

    • Figure Revenue and Market Share Analysis of Horizon Discovery Group Plc

    • Table Product and Service Introduction of Horizon Discovery Group Plc

    • Table Company Profile and Development Status of Caribou Biosciences, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Caribou Biosciences, Inc

    • Figure Sales and Growth Rate Analysis of Caribou Biosciences, Inc

    • Figure Revenue and Market Share Analysis of Caribou Biosciences, Inc

    • Table Product and Service Introduction of Caribou Biosciences, Inc

    • Table Company Profile and Development Status of Intellia Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intellia Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Intellia Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of Intellia Therapeutics, Inc

    • Table Product and Service Introduction of Intellia Therapeutics, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.